Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations

Publication
Article
BioPharm InternationalBioPharm International-10-15-2015
Volume 2015 eBook
Issue 2

This article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.

BioPharm International

eBooks Volume 28, Issue 14  

Assessing a drug candidate’s suitability during preformulation is essential to minimize the risk of costly downstream failure. Stability is a defining feature of biotherapeutic performance; measuring formulation stability during early-phase screening allows developers to make robust predictions of suitability for further development.    Read this article and other articles in

BioPharm International

's 2015

The Future of Bioprocessing

eBook.

Articles in this issue
BP1015-Fluctuating.gif
Fluctuating Capacity and Demand Conditions in Biomanufacturing
BP1015-Cleaning.gif
Cleaning Validation for Biologics
BP1015-Automation.gif
Automation of Single-Use Systems
BP1015-Aseptic.gif
Aseptic Processing for Cytotherapy, Regenerative Medicine, and Tissue-Engineered Products
BP1015-Patent.gif
Are Biopharma Patents Poised on the Post-Grant Chopping Block?
BP1015-Innovations.gif
Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations
BP1015-Raising-the-bar.gif
Raising the Bar for Biopharma Training
Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
David Fairen-Jimenez
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa Solutions
Eswar Iyer, Aikium Inc.
Leroy (Lee) Hood, MD, PhD
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Australia Regulatory Authority Declines Approval of Eisai’s Lecanemab for Early Alzheimer’s Disease

Feliza Mirasol
March 11th 2025
Article

The Therapeutic Goods Administration (TGA) of Australia confirmed its initial decision to decline approval of the mAb for treating early Alzheimer’s disease.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Magnified View of Lipid Nanoparticles | Image Credit: ©Aniwat - stock.adobe.com

Organic Nanoparticle-Based Drug-Delivery Systems as Alternatives to Lipid Nanoparticles

Cynthia A. Challener
March 9th 2025
Article

Exosomes, polymeric nanoparticles, and DNA nanostructures offer many potential advantages.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Macro view on vials | Image Credit: © yuriygolub - stock.adobe.com

Extractable and Leachable Challenges in Lyophilized Drug Products

Alan Xu;Piet Christiaens
March 6th 2025
Article

The authors examine the risks of extractables and leachables and present solutions that emphasize the importance of a strategic multi-prong approach.

High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com

Pushing Tech Boundaries

Mike Hennessy Jr.
March 3rd 2025
Article

Artificial intelligence, among other technological advances, is pushing innovation boundaries.

© 2025 MJH Life Sciences

All rights reserved.